Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionM&t Bank Corp
Latest Disclosed Ownership6,376 shares
Latest Disclosed Value $ 4,926,353
M&t Bank Corp ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 12, 2026 - M&t Bank Corp filed a 13F-HR form disclosing ownership of 6,376 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $4,926,353 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on January 30, 2026 disclosing 6,435 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -0.92% during the quarter.

M&t Bank Corp has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,376 -59 -0.92 4,926 -0.81 0.0040
2026-01-30 2025-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 6,435 1,096 20.53 4,966 65.48 0.0159
2026-01-28 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 15,689 10,350 484 0.0003
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,339 -590 -9.95 3,002 -3.60 0.0101
2025-08-13 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,929 843 16.57 3,113 -3.47 0.0107
2025-04-30 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,086 -282 -5.25 3,225 -15.66 0.0117
2025-02-06 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,368 -112 -2.04 3,825 -33.61 0.0128
2024-11-19 2024-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 5,480 224 4.26 5,761 4.27 0.0189
2024-11-15 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,480 224 5,761 0.0035
2024-07-31 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,256 -314 -5.64 5,524 3.04 0.0189
2024-05-07 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,570 241 4.52 5,361 14.53 0.0187
2024-02-06 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,329 -94 -1.73 4,681 4.88 0.0172
2023-11-02 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,423 25 0.46 4,463 15.11 0.0178
2023-08-09 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,398 2 0.04 3,878 -12.54 0.0145
2023-05-11 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,396 899 19.99 4,434 36.65 0.0172
2023-02-13 2022-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 4,497 -695 -13.39 3,245 -9.28 0.0131
2023-02-13 2022-12-31 13F REGENCY CTRS COM 75886F107 17,364 12,172 3,744 0.0151
2022-11-17 2022-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 5,192 -728 -12.30 3,576 24.77 0.0159
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,192 -728 3,410 0.0029
2022-08-05 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 5,920 1,662 39.03 2,866 -3.66 0.0135
2022-05-09 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,258 25 0.59 2,975 11.26 0.0131
2022-02-07 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,233 19 0.45 2,674 4.86 0.0112
2021-10-28 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,214 152 3.74 2,550 12.33 0.0115
2021-08-13 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,062 -34 -0.83 2,270 17.13 0.0100
2021-05-06 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,096 -1,489 -26.66 1,938 -28.20 0.0084
2021-02-12 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,585 -631 -10.15 2,699 -22.42 0.0118
2020-11-06 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 6,216 -1,036 -14.29 3,479 -23.08 0.0171
2020-07-29 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,252 -848 -10.47 4,523 14.39 0.0242
2020-05-14 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 8,100 -906 -10.06 3,954 16.91 0.0234
2020-02-07 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 9,006 545 6.44 3,382 44.10 0.0159
2019-11-12 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 8,461 3,609 74.38 2,347 54.61 0.0117
2019-08-12 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,852 -1,549 -24.20 1,518 -42.24 0.0079
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,401 -15 -0.23 2,628 9.73 0.0137
2019-02-01 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,416 -1,373 -17.63 2,395 -23.90 0.0137
2018-11-09 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,789 346 4.65 3,147 22.59 0.0157
2018-08-10 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 7,443 -670 -8.26 2,567 -8.12 0.0138
2018-05-04 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 8,113 -7,114 -46.72 2,794 -51.20 0.0150
2018-02-06 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 15,227 -2,341 -13.33 5,725 -27.12 0.0300
2017-11-13 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 17,568 -1,908 -9.80 7,855 -17.89 0.0426
2017-08-11 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 19,476 -3,843 -16.48 9,566 5.88 0.0565
2017-05-10 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 23,319 -26,628 -53.31 9,035 -50.72 0.0546
2017-02-14 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 49,947 -2,072 -3.98 18,335 -12.33 0.1142
2016-11-04 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 52,019 -4,846 -8.52 20,913 5.32 0.1333
2016-08-04 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 56,865 4,818 9.26 19,857 5.85 0.1336
2016-05-11 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 52,047 1,281 2.52 18,759 -31.93 0.1270
2016-02-12 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 50,766 3,274 6.89 27,558 24.74 0.1829
2015-11-13 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 47,492 -3,189 -6.29 22,092 -14.55 0.1505
2015-08-14 2015-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 50,681 -10,470 -17.12 25,853 -6.36 0.1559
2015-05-14 2015-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 61,151 1,483 2.49 27,608 12.78 0.1722
2015-02-12 2014-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 59,668 5,666 10.49 24,479 25.73 0.1532
2014-11-14 2014-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 54,002 40,013 286.03 19,470 392.66 0.1364
2014-08-13 2014-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 13,989 9,989 249.72 3,952 229.06 0.1653
2014-05-14 2014-03-31 13F REGENERON PHARMCTCLS COMMON 75886F107 4,000 -49 -1.21 1,201 7.81 0.0498
2014-02-12 2013-12-31 13F REGENERON PHARMCTCLS COMMON 75886F107 4,049 -1,107 -21.47 1,114 -30.94 0.0467
2013-11-13 2013-09-30 13F REGENERON PHARMCTCLS COMMON 75886F107 5,156 -1,220 -19.13 1,613 12.48 0.0770
2013-07-30 2013-06-30 13F REGENERON PHARMCTCSL COMMON 75886F107 6,376 6,376 1,434 0.0695
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-06 2020-09-30 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-29 2020-06-30 13F REGENERON PHARMACEUTICALS COM Call 3 25 n/a n/a n/a
2020-05-14 2020-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-07 2019-12-31 13F REGENERON PHARMACEUTICALS COM Call 20 -48.72 108 369.57 n/a n/a n/a
2019-11-12 2019-09-30 13F REGENERON PHARMACEUTICALS COM Call 39 95.00 23 -53.06 n/a n/a n/a
2017-05-10 2017-03-31 13F REGENERON PHARMACEUTICALS COM Call 20 49 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.